Search clinical trials for: Modulation of FiO2

Total 10000 results

‹
1
2
...
79
80
81
82
83
84
85
...
199
200
›

SCRI Development Innovations, LLC
Novartis; Genentech, Inc.

Terminated

Trial of the Combination of Bevacizumab and Everolimus in Patients With Refractory, Progressive Intracranial Meningioma

Intracranial Meningioma

United States
Rush University Medical Center

Withdrawn

Single Versus Multi-Dose Oral Tranexamic Acid in Patients at High Risk for Blood Transfusion After Total Joint Arthroplasty

Arthritis | Anemia | Total Knee Arthroplasty | Total Hip Arthroplasty

United States
Tulane University

Completed

Fibrinolysis Compared to Thoracoscopy for Pleural Infection

Pleural Diseases | Pleural Infection | Empyema | Parapneumonic Effusion

United States
Albert Einstein College of Medicine
National Cancer Institute (NCI)

Terminated

Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Adult Acute Myeloid Leukemia in Remission

United States
Institut Paoli-Calmettes

Completed

Safety and Efficacy of Revlimid® (Lenalidomide) With Mabthera® (Rituximab) in Non-Hodgkin's Lymphoma (R2)

Non-Hodgkin Lymphoma

France
Oregon Health and Science University
National Trauma Research Institute; Medical Research Foundation, Oregon

Completed

Thrombelastography Based Dosing of Enoxaparin

Thromboembolic Complications

United States
M.D. Anderson Cancer Center
Cortice Biosciences, Inc.

Terminated

Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma

Brain Neoplasms | Central Nervous System Neoplasms

United States
Bio-Thera Solutions

Completed

Study of Bevacizumab(BAT1706) and Comparators in Healthy Subjects

NSCLC

New Zealand
Institute of Liver and Biliary Sciences, India

Withdrawn

Efficacy and Safety of Acenocoumarol for Treatment of Nontumor Portal Vein Thrombosis in Cirrhosis of Liver

Portal Vein Thrombosis

India
National and Kapodistrian University of Athens

Completed

Role of Heparin in Poor Responders Undergoing In Vitro Fertilisation

Infertility

Greece
Johns Hopkins University

Completed

Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation

Atrial Fibrillation | Bradycardia | Tachycardia | Valvular Heart Disease

United States
Roswell Park Cancer Institute
Celgene

Completed

Lenalidomide With or Without Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Leukemia

United States
Hoffmann-La Roche

Completed

A Study of Bevacizumab Plus 5-Flurouracil (5-FU) Based Doublet Chemotherapy as Neoadjuvant Therapy for Participants With Previously Untreated Unresectable Liver-Only Metastases From Colorectal Cancer

Colorectal Cancer

China
Genentech, Inc.

Completed

A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO) (BRAVO)

Macular Edema | Retinal Vein Occlusion
Max Sung

Terminated

Biological Therapy in Treating Women With Breast Cancer That Has Spread to the Liver

Breast Cancer | Metastatic Cancer

United States
Bayer

Terminated

Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration (DREAM)

Macular Degeneration

Hong Kong, Korea, Republic of, United States, Canada, Switzerland, Spain, Japan, Italy, Czech Republic, Australia, Austria, Slovakia, Germany, Hungary, Israel, Chile, France, Colombia
Regeneron Pharmaceuticals
Bayer

Completed

Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema (VISTA DME)

Diabetic Macular Edema

United States
David M. Brown, M.D.
Novartis Pharmaceuticals

Terminated

Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
Amgen

Completed

A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma

Carcinoma | Cancer | Metastatic Colorectal Cancer | Colorectal Cancer | Rectal Cancer | Metastatic Cancer | Colon Cancer | Gastrointestinal Cancer | Oncology | Metastases
Neuroscience Trials Australia

Terminated

Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial (EXTEND-IA)

Ischemic Stroke

Australia, New Zealand
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Withdrawn

Lenalidomide With or Without Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Undergone Autologous or Syngeneic Stem Cell Transplant

Lymphoma | Leukemia
Regeneron Pharmaceuticals
Bayer

Completed

Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in Patients With Branch Retinal Vein Occlusion (BRVO) (VIBRANT)

Branch Retinal Vein Occlusion

United States, Japan, Canada
Alcon Research

Completed

Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD

Macular Degeneration

United States
Gruppo Italiano Studio Linfomi

Unknown

Lenalidomide Plus Rituximab (R) in Non Follicular NHL

Indolent Non Hodgkin Lymphoma

Italy
Tehran University of Medical Sciences

Withdrawn

The Effect of Heparin on Inhalation Injury

Heparin

Iran, Islamic Republic of
Novartis

Completed

Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV)

Polypoidal Choroidal Vasculopathy

Hong Kong, Taiwan, Singapore, Korea, Republic of, Thailand
Azidus Brasil

Unknown

Comparison of Two Heparin Formulations in Patients With Chronic Renal Failure. (HEPHIP0509)

Thrombus

Brazil
Simcere Pharmaceutical Co., Ltd
Daping Hospital and the Research Institute of Surgery of the Third Military...

Unknown

Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

China
Speedel Pharma Ltd.
Quintiles, Inc.

Completed

A Clinical Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Heparin in Patients Who Are on Haemodialysis

Chronic Kidney Failure | Vascular Graft Occlusion

United States
Shahid Beheshti University of Medical Sciences

Unknown

The Effect of 5-FU and LMW Heparin on the Rate of Retinal Redetachment After Silicone Oil Removal in Cases of PVR

Proliferative Vitreoretinopathy

Iran, Islamic Republic of
Anhui Provincial Hospital
Qilu Hospital of Shandong University; Henan Provincial People's Hospital; The... and other collaborators

Not yet recruiting

A Single-Arm, Multicenter, Exploratory Clinical Study of Transarterial Chemoembolization (TACE) Combined With Iparomlimab and Tuvonralimab Injection and Bevacizumab Injection for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma (HCC) | Immunotherapy | PD-1 | TACE | CTLA-4
The Affiliated Hospital of Xuzhou Medical University

Not yet recruiting

Iparomlimab and Tuvonralimab Injection (QL1706) Combined With Bevacizumab for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma (HCC) With High Risk of Recurrence

Adjuvant Treatment | HCC - Hepatocellular Carcinoma
Obstetrics & Gynecology Hospital of Fudan University

Not yet recruiting

ctDNA-guided First-line Immuno-de-escalation Therapy for IVB-stage and Recurrent Cervical Cancer

Uterine Cervical Neoplasm

China
Fudan University

Recruiting

Second-line Standard Treatment Sequential TAS-102 and Bevacizumab Combined With Local Treatment in Advanced Colorectal Cancer (TASBEL)

Metastatic Colorectal Cancer (CRC)

China
Shanghai Zhongshan Hospital

Not yet recruiting

PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7

Hepatocellular Carcinoma
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

Chidamide Combined With Sintilimab and Bevacizumab for the First-line Treatment of Advanced Liver Cancer

Liver Cancer
Tang-Du Hospital

Not yet recruiting

Treatment of Low Locally Advanced Rectal Cancer With Radiotherapy Removal TNT Plus Neoadjuvant Therapy

Rectal Cancer
West China Hospital

Recruiting

Capeox Regimen Combined With Sintilimab and Bevacizumab for Gastric Cancer

Stomach Neoplasm

China
Hawler Medical University

Recruiting

Two Different Regimens of Bemiparin as a Thromboprophylaxis in Morbidly Obese Surgical Patients

Morbid Obesity

Iraq
Fudan University

Recruiting

mFOLFOXIRI+Bev vs. mFOLFOX6+Bev for RAS Mutant Unresectable Colorectal Liver-limited Metastases

Liver Metastases | Colorectal Carcinoma

China
Yong Chen

Recruiting

Endostar Combined With AI Regimen Compared With AI in Adjuvant Treatment

Other Disorders of Soft Tissues

China
The First Hospital of Hebei Medical University

Completed

TACE Plus Bevacizumab for Hepatocellular Carcinoma With Portal Vein Invasion

Hepatocellular Carcinoma (HCC)

China
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Completed

601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO)

Central Retinal Vein Occlusion

China
Combined Military Hospital Multan

Completed

Tranexamic Acid to Reduce Blood Loss in Women Having Planned Cesarean Section

Cesarean Section | Blood Loss During Surgery

Pakistan
Ophthotech Corporation

Completed

A Study to Establish the Safety and Tolerability of Zimura™ (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)

Idiopathic Polypoidal Choroidal Vasculopathy

United States
Mayo Clinic

Completed

The Randomized OPTIMAL-ACT Trial

Coronary Artery Disease | Ischemic Heart Disease | Anticoagulant-induced Bleeding | Coronary Syndrome

United States
Second Affiliated Hospital of Soochow University

Enrolling by invitation

Chidamide in Patients With Recurrent and Refractory Diffuse Large b

Diffuse Large B-cell Lymphoma

China
University of Manitoba
Canadian Institutes of Health Research (CIHR); CancerCare Manitoba

Terminated

Heparin Anticoagulation in Septic Shock (HALO)

Septic Shock | Vasodilatory Shock

Canada, United States, Brazil, Greece, India, Pakistan, Philippines
Ain Shams University

Completed

D-Dimer as Predictor of Disease Outcome in Intensive Care Unit in COVID-19m Patients (COVID-19)

Pneumonia, Viral | Critical Illness

Egypt
National Institute of Allergy and Infectious Diseases...

Completed

A Study to Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3

HIV Infections

United States

‹
1
2
...
79
80
81
82
83
84
85
...
199
200
›

Subscribe